Scarica l'app Stockscreener
7.02
3.17%
-0.23
Dopo l'orario di chiusura:
6.80
-0.22
-3.13%
Decoy Therapeutics Inc Borsa (DCOY) Ultime notizie
DCOYDecoy Therapeutics Inc Latest SEC Filings - Finviz
DCOY Q3 2024 Earnings: Narrower-than-Expected Loss Fails to Stem Stock DeclineRevenue Growth Report - dars.gov.et
Decoy stock rises after announcing up to $21 million private placement financing - MSN
Decoy Therapeutics Inc. Financial Disclosures & Filings - TradingView
Crude Oil Gains 2%; Comcast Shares Spike Higher - Sahm
Market Movers | Winners: TRNR, DCOY, ATLN | Losers: BJDX, EVMN, CELZ - Trefis
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
Decoy Therapeutics secures $3.5M PIPE financing; shares surge - MSN
User - The Chronicle-Journal
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
DCOY Stock Nearly Doubled In Value Today – What’s Driving This Mega Rally? - Asianet Newsable
Trending Stocks Today | Universe Pharmaceuticals Soars 333.17% - Moomoo
DCOY Stock Explodes Higher As Volatile Biotech Trading Heats Up - StocksToTrade
Decoy Stock Rises After Announcing Up to $21 Million Private Placement Financing - Benzinga
Decoy Therapeutics Secures Up to $21 Million PIPE Financing to Advance Multi-Antiviral Clinical Trials - Minichart
DCOY Stock Whipsaws As Traders Eye Volatile Setup - timothysykes.com
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Morning Market Movers: UPC, DCOY, CMSA, LRMR See Big Swings - RTTNews
Decoy Therapeutics Secures PIPE Financing to Advance Trials - TipRanks
Decoy Therapeutics Raises $3.5 Million in Private Placement at $5.91, Adds Milestone Warrants - TradingView
Decoy Therapeutics (NASDAQ: DCOY) lines up $21M milestone-based PIPE funding - Stock Titan
$Decoy Therapeutics (DCOY.US)$ - Moomoo
Decoy Therapeutics Inc. Actuals & Estimates (FWB:FP11) - TradingView
Decoy Therapeutics Inc. Actuals & Estimates (BOATS:DCOY) - TradingView
Decoy Therapeutics secures $3.5M financing with investor By Investing.com - Investing.com Australia
DECOY THERAPEUTICS, INC. ANNOUNCES UP TO $21 MILLION PRIVATE PLACEMENT FINANCING - Moomoo
Decoy Therapeutics, Inc. Announces Up to $21 Million Private Placement Financing - Lake Geneva News
Decoy Therapeutics Inc. Actuals & Estimates (GETTEX:FP11) - TradingView
Decoy Therapeutics Inc. Actuals & Estimates (MUN:FP11) - TradingView
Decoy Therapeutics Inc. Actuals & Estimates (NASDAQ:DCOY) - TradingView
[EFFECT] Decoy Therapeutics Inc. SEC Filing - Stock Titan
Decoy Therapeutics (DCOY) Stock Forum and Discussion - Moomoo
Decoy Therapeutics (NASDAQ: DCOY) files S-1 for 808,000-share equity line resale - Stock Titan
Decoy Therapeutics: David Arthur Completing His Service on the Board >DCOY - Moomoo
Decoy Therapeutics' CEO to Participate in hVIVO Capital Markets Day in London - Morningstar
[RW] Decoy Therapeutics Inc. SEC Filing - Stock Titan
DCOY SEC FilingsDECOY THERAPEUTICS INC 10-K, 10-Q, 8-K Forms - Stock Titan
DCOY Q3 2024 Earnings: Narrower-Than-Expected Losses Mask Pipeline UncertaintyRevenue Report - dars.gov.et
DCOY | Decoy Therapeutics Inc. Common Executive Compensation - Quiver Quantitative
Decoy Therapeutics (DCOY) details 2026 director, pay and auditor votes - Stock Titan
DCOY Q3 2024 Earnings: Narrower-Than-Expected Loss Fails to Offset Investor ConcernsTrough Earnings Signal - dars.gov.et
Decoy Therapeutics nominates Patricia Gauthier to board - Investing.com UK
Decoy Therapeutics nominates Patricia Gauthier to board By Investing.com - Investing.com South Africa
Decoy Therapeutics Nominates Global Biopharma Executive Patricia Gauthier for Election to Board of Directors - PR Newswire
hVIVO win with Decoy Therapeutics signals shift towards broader contract research market, says broker - Proactive Investors
Decoy Therapeutics Partners with hVIVO to Advance Lead D-MAV™ Ca - GuruFocus
hVIVO signs consultancy deal with antiviral developer Decoy Therapeutics - Proactive Investors
hVIVO to support Decoy Therapeutics respiratory antiviral development - Vox Markets
hVIVO signs consultancy deal with Decoy Therapeutics By Investing.com - Investing.com Canada
Decoy Therapeutics Partners with hVIVO to Advance Lead D-MAV™ Candidate into the Clinic - Financial Times
1.17%
2.48%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):